Lymph Node Evaluation after Neoadjuvant Chemotherapy for Patients with Gastric Cancer

被引:11
|
作者
Shannon, Adrienne B. [1 ]
Straker, Richard J., III [1 ]
Keele, Luke [1 ]
Fraker, Douglas L. [2 ]
Roses, Robert E. [2 ]
Miura, John T. [2 ]
Karakousis, Giorgos C. [2 ]
机构
[1] Hosp Univ Penn, Dept Surg, 3400 Spruce St, Philadelphia, PA 19104 USA
[2] Hosp Univ Penn, Dept Surg, Div Endocrine & Oncol Surg, 3400 Spruce St, Philadelphia, PA 19104 USA
关键词
SURVIVAL; METAANALYSIS; OUTCOMES; SURGERY; IMPACT;
D O I
10.1245/s10434-021-10803-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adequate lymphadenectomy with at least 16 nodes retrieved at the time of gastrectomy is a quality measure recommended to ensure adequate staging. The minimum nodal retrieval recommended after receipt of neoadjuvant chemotherapy (NACT) is less defined. Methods Patients with clinical stages 1 to 3 gastric adenocarcinoma who received NACT and surgical resection were identified from the 2004-2015 National Cancer Database. The optimal nodal harvest number was calculated with Cox spline regression modeling. Cohorts with a nodal harvest higher or lower than this number were 1:1 propensity score-matched. Overall survival (OS) was analyzed using Kaplan-Meier survival estimates. Results Among 4337 patients receiving NACT, the optimal minimal nodal harvest at gastrectomy was 23 nodes. Compared with the patients who had fewer than 23 nodes retrieved, the patients with at least 23 nodes examined (n = 1073, 24.7%) were more likely to be female (26.1% vs 22%; p = 0.006) and non-white (29.3% vs 18.5%; p < 0.0001), to have a Charlson-Deyo score of 0 (71.5% vs 66.8%; p = 0.005), and to have undergone resection at an academic facility (67.9% vs 51.5%; p < 0.0001). The patients with at least 23 nodes examined had higher proportions of high-grade tumor (62% vs 57.4%; p = 0.030), pT3 or pT4 tumor (56.3% vs 48.7%; p < 0.0001), body tumor (21.3% vs 12.5%; p < 0.0001), or antrum/pylorus tumor (15.3% vs 11.4%; p < 0.0001). The patients with at least 23 nodes were more likely to have lymph node metastases identified (61% vs 51%; p < 0.0001). After matching, the patients with at least 23 nodes (n = 990) demonstrated an improved 5-year OS (57.9% vs 49%; p = 0.001). Conclusions The extent of lymphadenectomy during gastrectomy for gastric adenocarcinoma should not be reduced after NACT because adequate lymph node retrieval remains important for prognostication.
引用
收藏
页码:1242 / 1253
页数:12
相关论文
共 50 条
  • [31] Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy
    Kim, Hyunhee
    Han, Jaihong
    Kim, Sun-Young
    Lee, Eun Sook
    Kang, Han-Sung
    Lee, Seeyoun
    Jung, So-Youn
    Lee, EunGyeong
    [J]. JOURNAL OF BREAST CANCER, 2021, 24 (06) : 531 - 541
  • [32] Total Lymph Node Yield is Associated with Prolonged Survival After Neoadjuvant Chemotherapy in ypN0 Gastric Cancer Patients
    Li, Weikun
    Shao, Xinxin
    Ma, Fuhai
    Wang, Bingzhi
    Xue, Liyan
    Hu, Haitao
    Kang, Wenzhe
    Xiong, Jianping
    Tian, Yantao
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (7-8) : 287 - 294
  • [33] Decreased axillary lymph node retrieval in patients after neoadjuvant chemotherapy
    Baslaim, MM
    Al Malik, OA
    Al-Sobhi, SS
    Ibrahim, E
    Ezzat, A
    Ajarim, D
    Tulbah, A
    Chaudhary, MA
    Sorbris, RA
    [J]. AMERICAN JOURNAL OF SURGERY, 2002, 184 (04): : 299 - 301
  • [34] Sentinel lymph node biopsy in patients with locally advanced breast cancer after neoadjuvant chemotherapy
    Walter Aguiar, Paulo Henrique
    Porto Pinheiro, Luiz Gonzaga
    Salani Mota, Rosa Maria
    Gurjao Margotti, Nair Hermnia
    Xavier Rocha, Joao Ivo
    [J]. ACTA CIRURGICA BRASILEIRA, 2012, 27 (12) : 912 - 916
  • [35] Role of micrometastases in sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients
    Ponce, J.
    Delgado, S.
    Ballester, H.
    Martin, T.
    Peiro, G.
    Montoyo-Pujol, Y. G.
    Garcia-Escolano, M.
    Aranda, F.
    Niveiro, M.
    Reche, M.
    Rodriguez-Lescure, A.
    Lozano, I.
    Massuti Sureda, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S323 - S323
  • [36] Analysis of sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Jinno, H
    Ikeda, T
    Kitajima, M
    Fujii, H
    Mukai, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S41 - S41
  • [37] Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with initial axillary node metastasis
    Testart, N.
    Rebollo-Aguirre, A. C.
    Sanchez-Sanchez, R.
    Aroui, T.
    Trivino-Ibanez, E. M.
    Garcia-Garcia, J.
    Menjon-Beltran, S.
    Llamas-Elvira, J. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S706 - S706
  • [38] Omitting axillary lymph node dissection in breast cancer patients with metastatic sentinel node after neoadjuvant chemotherapy
    Kuru, B.
    Ozen, N.
    Yuruker, S.
    Sullu, Y.
    Gursel, B.
    Karabacak, U.
    Akgun, C.
    Yucel, I.
    [J]. BREAST, 2021, 56 : S76 - S77
  • [39] Prognostic impact of axillary lymph node status after neoadjuvant chemotherapy for patients with breast cancer
    Nakamura, R.
    Yamamoto, N.
    Miyaki, T.
    Itami, M.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [40] Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy.
    Kinoshita T.
    [J]. Breast Cancer, 2007, 14 (1) : 10 - 15